Third quarter 2013 basic and diluted earnings per share were both $0.25, compared to $0.31 and $0.30 respectively in the third quarter of 2012. Third quarter 2013 basic and diluted non-GAAP earnings per share were $0.48 and $0.47 respectively, compared to $0.43 and $0.42 in the third quarter of 2012. Shares used in the computation of diluted earnings per share for the third quarter 2013 were 121.2 million.
Other Select DataAccounts receivable turnover days were 56 days in the third quarter of 2013, improved from 66 days in the third quarter of 2012 and compared to 52 days in the second quarter of 2013. Inventory turnover days were 94 days in the third quarter of 2013, shorter than 100 days in the third quarter of 2012 and compared to 88 days in the second quarter of 2013. Accounts payable turnover days were 59 days in the third quarter of 2013, compared to 60 days in the third quarter of 2012 and 54 days in the second quarter of 2013. Mindray calculates the above working capital turnover days using the average of the beginning and ending net balances of the quarter.
As of September 30, 2013, the company had $1 billion in cash and cash equivalents as well as short-term investments, compared to $958.5 million as of June 30, 2013. Net cash generated by operating activities and net cash outflow for capital expenditures during the quarter were $67.1 million and $26.9 million respectively.
As of September 30, 2013, the company had around 7,860 employees.
Business Outlook for Full Year 2013Mindray revises its full year 2013 net revenues guidance and now forecasts at least 13% growth over its full year 2012 net revenues.
The company also updates its full year 2013 non-GAAP net income guidance and projects at least 11% growth over its non-GAAP net income for the full year of 2012. This guidance excludes any tax benefi
|SOURCE Mindray Medical International Limited|
Copyright©2012 PR Newswire.
All rights reserved